Role of islet amyloid in type 2 diabetes mellitus: consequence or cause? (Q34997064)

5 August 2017

1 reference

title

Role of islet amyloid in type 2 diabetes mellitus: consequence or cause? (English)

1 reference

5 August 2017

1 reference

4

Bo Ahrén

1 reference

5 August 2017

Jo W M Höppener

1

1 reference

5 August 2017

Maria G Nieuwenhuis

series ordinal

2

1 reference

5 August 2017

Thea M Vroom

series ordinal

3

1 reference

5 August 2017

Cees J M Lips

series ordinal

5

1 reference

5 August 2017

1 November 2002

1 reference

Molecular and Cellular Endocrinology

5 August 2017

1 reference

5 August 2017

197

1 reference

5 August 2017

1-2

1 reference

5 August 2017

205-212

1 reference

Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice.

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Non-linkage of the islet amyloid polypeptide gene with Type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Amyloidosis: a review of recent diagnostic and therapeutic developments

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

A feline model of experimentally induced islet amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Molecular physiology of the islet amyloid polypeptide (IAPP)/amylin gene in man, rat, and transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Longitudinal studies on the development of diabetes in individual Macaca nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Anti-amyloid drugs: potential in the treatment of diseases associated with aging

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Diabetes trends in the U.S.: 1990-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid polypeptide: identification and chromosomal localization of the human gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid polypeptide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 (non-insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

THE RELATION OE DIABETES MELLITUS TO LESIONS OF THE PANCREAS. HYALINE DEGENERATION OF THE ISLANDS OE LANGERHANS.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Effects of medical research on health care and economy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Missense mutation of amylin gene (S20G) in Japanese NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

The U.K. Prospective Diabetes Study. A review.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Ueber eine im Gehirn und Rückenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Amyloid and polypeptide hormones: What is their interrelationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900266-6

7 January 2021

10.1016/S0303-7207(02)00266-6

Identifiers

DOI

1 reference

5 August 2017

1 reference